A Study of Treatment Success in Changing From Olanzapine to Long-acting Injectable Risperidone (RISPERDAL® CONSTA™)
- Status
- COMPLETED
- Phase
- PHASE4
Clinical Trials Related to Schizophrenia
Related studies linked through entity extraction aliases.
A Pilot Study of the Use of Risperidone Long Acting Injectable in the Treatment of Patients With Recent Onset Psychosis
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Evaluate Symptomatic Remission in Schizophrenia With Long Acting Risperidone Microspheres
- Status
- COMPLETED
- Phase
- PHASE4
A Study of Relapse Prevention and the Effectiveness of Long-acting Injectable Risperidone and Quetiapine Tablets in the Treatment of Patients With Schizophrenia or Schizoaffective Disorder
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy and Safety Study of Clozapine Augmented by Atomoxetine Versus Clozapine Augmented by Placebo in Patients With Chronic Resistant Schizophrenia
- Status
- TERMINATED
- Phase
- PHASE3
D-Serine Monotherapy for Schizophrenia
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Determining the Effects of Risperdal Consta in Patients With Psychotic Disorders and Incomplete Adherence
- Status
- COMPLETED
- Phase
- PHASE4
Seroquel on Glucose Metabolism
- Status
- COMPLETED
- Phase
- PHASE4
Efficacy and Safety of Asenapine Compared With Olanzapine in Patients With Persistent Negative Symptoms of Schizophrenia (25543)(COMPLETED)(P05817)
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy and Safety of Asenapine Using an Active Control in Subjects With Schizophrenia or Schizoaffective Disorder (25517)(P05935)
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy and Safety of Asenapine Using an Active Control in Subjects With Schizophrenia or Schizoaffective Disorder (25520)(P05846)
- Status
- COMPLETED
- Phase
- PHASE3
Adjunctive Supplementation of Antioxidants (Vitamins E + C) Plus Omega-3 Fatty Acids
- Status
- TERMINATED
- Phase
- PHASE3
Cognitive Improvement With Aripiprazole (Abilify) in Patients With Schizophrenia (SFBRI)
- Status
- TERMINATED
- Phase
- NA
Cognitive Improvement With Aripiprazole (Abilify) in Patients With Schizophrenia (BMS)
- Status
- TERMINATED
- Phase
- NA
A Study of the Long-term Safety and Tolerability and the Long-term Effectiveness of Extended-release Oral Paliperidone in Patients Diagnosed With Schizophrenia
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Compare the Effectiveness and Safety of Flexibly Varied Doses of Paliperidone Palmitate and Risperidone in Treating Patients With Schizophrenia
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Long-acting Injectable Risperidone in the Treatment of Patients With Schizophrenia or Schizoaffective Disorder
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Evaluate the Effectiveness and Safety of 3 Doses of Paliperidone Palmitate in Treating Subjects With Schizophrenia
- Status
- COMPLETED
- Phase
- PHASE3
The Effects of Aripiprazole on the Processing of Rewards in Schizophrenia
- Status
- TERMINATED
- Phase
- NA
Abilify Therapy for Reducing Comorbid Substance Abuse
- Status
- COMPLETED
- Phase
- PHASE4